Evalve
Evalve, Inc. was a medical-device company that pioneered percutaneous (catheter-based) mitral valve repair with its MitraClip system for treating mitral regurgitation. It was acquired by Abbott Laboratories in 2009 (~$410M) and folded into Abbott Structural Heart / Abbott Vascular; MitraClip is now an Abbott product. Evalve does not exist as an independent operating company and publishes no developer program, public API, SDKs, or developer documentation. The former evalve.com domain is a parked, for-sale page. Surfaced here as a kleiner-perkins portfolio lead, this is a non-API, defunct/acquired entity with no enrichable API surface.
Evalve is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Medical Devices, Cardiology, and Structural Heart.